JOIN OUR FREE LIVE WEBINAR!
Method Robustness and Transferability for Modern Size-Exclusion Methods
Helen Whitby, PhD
Senior Product Manager – Bioseparations, Phenomenex
Tuesday November 7, 2023
10:00 AM - 11:00 AM (PT)
Key Learning Points:
- Understand the impact of HPLC/UHPLC systems, including bio-inert and traditional stainless-steel configurations
- Learn how to transition from a legacy SEC method to improve analytical method throughput and data quality
- Determine the experimental parameters to vary to ensure demonstration of analytical method robustness
Who Should Attend:
- Any scientists who are looking to learn more about method parameters and variables to consider for developing a robust and transferable method.
Speaker Bios:
Dr. Helen Whitby is the senior product manager for biopharma at Phenomenex. Helen has been with Phenomenex since 2007, starting in the UK sales team as a bulk and prep specialist before joining the technical team in 2016. Helen spent 6 years as a biopharma specialist in the technical team supporting all our biopharma products globally before moving to product management in 2022. Helen has a PhD from the University of Manchester working on analogues of Shikimic acid to treat malaria. Prior to joining Phenomenex, Helen spent a year as a Post-doctoral researcher at the University of Illinois in Chicago, where she studied electron-deficient divalent reactive intermediates, specifically nitrenium ions for the development of antiviral agents to treat Ebola.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
